Impar Serviços Hospitalares S/A

São Paulo, São Paulo 01409-902

0 studies enrolling now · 1 studies all time

What they study most

Cardiovascular Risk, Chronic Kidney Disease, Inflammation

Studies at this site

• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed